Gabe Jones has over a decade of leadership experience in technology and intellectual property law, with specific expertise in product development, business strategy and engineering management. He began his career in international trade and IP law in Japan and Washington, DC, and worked in large-scale mergers and acquisitions on Wall Street.
Prior to joining Proprio he helped Bill Gates evaluate technologies while working with the Bill & Melinda Gates Foundation on global initiatives in health and technology. Seeking to create a more direct, positive societal impact in the health systems space, his work has led him to the technology venture world. He has assisted several successful startups on their commercialization path, notably in the complex process of pursuing FDA approvals for pharmaceuticals and medical devices. Gabe has worked extensively with Proprio Chairman of the Board, Ken Denman, and has held seats on the boards of the Washington Biotech and Biomedical Association and the Group Health Foundation through its acquisition by Kaiser.